Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

18.06 +0.17 (+0.95%)
Streaming Delayed Price Updated: 12:19 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
News headline image
What's Next for Novocure? ↗
The company has several key data readouts on the way. 
Via The Motley Fool
News headline image
Delta Outbreak ↗
The US market was droopy because of poor private sector jobless numbers. 
Via Talk Markets
News headline image
Cramer Advises Viewers On Palantir, SoFi And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.... 
Via Benzinga
News headline image
Know When To Hold 'Em, Know When To Fold 'Em ... ↗
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
News headline image
NovoCure: Q2 Earnings Insights ↗
Shares of NovoCure (NASDAQ:NVCR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were down 800.00% over the past year to ($0... 
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2021 ↗
Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is... 
Via Benzinga
News headline image
Here's Why Novocure Dipped 19% This Week ↗
Uptake of the company's revolutionary disease-controlling device isn't progressing as quickly as expected. 
Via The Motley Fool
News headline image
70 Biggest Movers From Yesterday ↗
Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private... 
Via Benzinga
News headline image
News Overload ↗
Today US markets managed a rally despite misses in both the growth and employment data. 
Via Talk Markets
News headline image
Why Novocure Tanked on Thursday ↗
Investors are seeing red in the company's latest earnings report. 
Via The Motley Fool
News headline image
NovoCure (NVCR) Q2 2021 Earnings Call Transcript ↗
NVCR earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Novocure Stock Dips As Q2 Earnings Trail Estimates; Higher Costs Hit Bottom Line ↗
Novocure Ltd (NASDAQ: NVCR) posted a net loss of $14.6 million in Q2, compared to a net income of $1.7 million a year ago. EPS came in at $(0.14), missing the consensus... 
Via Benzinga
News headline image
Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update
From Novocure
Via Business Wire
News headline image
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Full News Day ↗
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
News headline image
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
News headline image
Containment Plan ↗
Today the US decided to cut China risks. 
Via Talk Markets
News headline image
Joblessness Surprise ↗
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices. 
Via Talk Markets
News headline image
“Claw-Back” day ↗
The rally was just as irrational as the selloff. 
Via Talk Markets
News headline image
Weak Week ↗
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. 
Via Talk Markets
News headline image
Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
From Novocure
Via Business Wire
News headline image
Yellow Card ↗
The price of oil fell about 1% today. 
Via Talk Markets
News headline image
Novocure to Report Second Quarter 2021 Financial Results
From Novocure
Via Business Wire
News headline image
Fireworks Display ↗
The oil price rose to 76.81/bbl after the OPEC attempt to have a meeting to agree to boost production (and cut prices) was blocked. 
Via Talk Markets
News headline image
People Needed ↗
If qualified people are not looking for work, they will have to be lured to do so with higher wages. 
Via Talk Markets
News headline image
Stock Market Rally: S&P 500, Nasdaq Hit Highs; Facebook, Tesla, Nio, Intellia, Didi IPO, OPEC+ In Focus ↗
The S&P 500 and Nasdaq hit record highs last week. Facebook hit a $1 trillion market cap. Tesla deliveries jumped. 
Via Investor's Business Daily
Topics Initial Public Offering Stocks
News headline image
Analyzing NovoCure's Unusual Options Activity ↗
Shares of NovoCure (NASDAQ:NVCR) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved down to $184.64. Sentiment: BEARISH... 
Via Benzinga
News headline image
New Month And Half Year ↗
Welcome to H2. In theory, if markets did well in H1 they tend to close the year up. 
Via Talk Markets
News headline image
58 Biggest Movers From Yesterday ↗
Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share. Pop Culture Group Co., Ltd (... 
Via Benzinga
Topics Initial Public Offering
News headline image
Why Did Novocure Shares Plunge Today? ↗
Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.